Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AcuityAds Holdings Inc. stock logo
ATY
AcuityAds
$1.80
$1.38
$3.66
$90.92M1.2656,165 shs10,300 shs
Mechel PAO stock logo
MTL
Mechel PAO
$2.25
$2.28
$1.58
$5.19
N/AN/AN/AN/A
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
$0.08
+10.3%
$0.12
$0.07
$1.42
$3.06M1.973.34 million shs1.41 million shs
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AcuityAds Holdings Inc. stock logo
ATY
AcuityAds
0.00%0.00%0.00%0.00%+10.81%
Mechel PAO stock logo
MTL
Mechel PAO
0.00%0.00%0.00%0.00%0.00%
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
+0.52%-7.50%-43.61%-52.62%+7,769,900.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AcuityAds Holdings Inc. stock logo
ATY
AcuityAds
N/AN/AN/AN/AN/AN/AN/AN/A
Mechel PAO stock logo
MTL
Mechel PAO
N/AN/AN/AN/AN/AN/AN/AN/A
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AcuityAds Holdings Inc. stock logo
ATY
AcuityAds
N/AN/AN/AN/A
Mechel PAO stock logo
MTL
Mechel PAO
N/AN/AN/AN/A
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AcuityAds Holdings Inc. stock logo
ATY
AcuityAds
$121.04M0.00N/A28.83$1.40 per share0.00
Mechel PAO stock logo
MTL
Mechel PAO
$5.46BN/AN/AN/AN/AN/A
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
$14.73M0.21N/AN/A$0.12 per share0.71

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AcuityAds Holdings Inc. stock logo
ATY
AcuityAds
-$580K-$0.01N/AN/AN/A-1.39%-5.84%-4.46%N/A
Mechel PAO stock logo
MTL
Mechel PAO
$1.10BN/A0.00N/AN/AN/AN/AN/A
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
-$9.64M-$3.82N/A1.21N/A-65.46%-150.14%-53.48%5/28/2024 (Estimated)

Latest MTL, MKA, ATY, TSTR, and NBY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/26/2024Q4 2023
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
N/A-$0.95-$0.95-$0.57N/A$3.73 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AcuityAds Holdings Inc. stock logo
ATY
AcuityAds
N/AN/AN/AN/AN/A
Mechel PAO stock logo
MTL
Mechel PAO
N/AN/AN/AN/AN/A
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AcuityAds Holdings Inc. stock logo
ATY
AcuityAds
0.04
3.69
3.69
Mechel PAO stock logo
MTL
Mechel PAO
N/AN/AN/A
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
N/A
1.67
1.00

Ownership

Institutional Ownership

CompanyInstitutional Ownership
AcuityAds Holdings Inc. stock logo
ATY
AcuityAds
8.66%
Mechel PAO stock logo
MTL
Mechel PAO
N/A
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
23.25%

Insider Ownership

CompanyInsider Ownership
AcuityAds Holdings Inc. stock logo
ATY
AcuityAds
11.98%
Mechel PAO stock logo
MTL
Mechel PAO
36.34%
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
1.30%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
AcuityAds Holdings Inc. stock logo
ATY
AcuityAds
18756.83 million50.02 millionNot Optionable
Mechel PAO stock logo
MTL
Mechel PAO
51,414N/AN/AOptionable
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
2436.06 million35.59 millionNot Optionable

MTL, MKA, ATY, TSTR, and NBY Headlines

Company Descriptions

AcuityAds logo

AcuityAds

NYSE:ATY
AcuityAds Holdings, Inc. engages in the provision of digital advertising solutions. It operates through the following geographical segments: Unites States, Canada, and Europe and Other. The company was founded by Tal Hayek, Nathan Mekuz, Rachel Kapcan, and Joe Ontman on October 9, 2009 and is headquartered in Toronto, Canada.
Mechel PAO logo

Mechel PAO

NYSE:MTL
Mechel PAO, together with its subsidiaries, engages in mining, steel, and power businesses in Russia, Asia, Europe, the Commonwealth of Independent States, and internationally. The Mining segment produces and sells coking and steam coals, middlings, coke and chemical products, and iron ore concentrate. The Steel segment produces and sells semi-finished steel products; carbon and specialty long products; carbon and stainless flat products; and value-added downstream metal products, including forgings, stampings, hardware, rails, and ferrosilicon. The Power segment generates and supplies electricity and heat power to the third parties. It also provides transportation and freight services. The company was formerly known as Mechel OAO and changed its name to Mechel PAO in March 2016. Mechel PAO was incorporated in 2003 and is based in Moscow, Russia.
NovaBay Pharmaceuticals logo

NovaBay Pharmaceuticals

NYSE:NBY
NovaBay Pharmaceuticals, Inc., a biopharmaceutical company, develops and sells eyecare, skincare, and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products, which are used for cleansing and irrigation as part of surgical procedures, as well as treating certain wounds, burns, ulcers, and other injuries under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, hyperhidrosis, excessive hair, and acne under the DERMAdoctor brand. It sells its products through traditional and digital beauty retailers and distributors, as well as online. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.